{
    "nctId": "NCT04303715",
    "briefTitle": "No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography",
    "officialTitle": "No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography[NAUTILUS]: A Prospective, Multicenter, Phase III Clinical Trial",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer, Sentinel Lymph Node",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 1734,
    "primaryOutcomeMeasure": "invasive Disease Free Survival (iDFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women \u2265 19 years\n* Invasive unilateral breast carcinoma with histological confirmation\n* History of invasive breast cancer\n* Histologically or radiologically no suspicion of distant metastases\n* Performance status corresponding to ECOG grade 0-2\n* Tumor size clinically and radiologically \u2264 5cm, independent of hormone receptor and HER2 status\n* Clinically and sonographically negative axillary lymph nodes before biopsy; core needle biopsy or fine needle aspiration of suspicious lymph node required\n* BCS candidate with postoperative whole-breast irradiation and adequate systemic therapy\n* No psychological and geographical restriction in follow-up\n* Written informed consent\n\nExclusion Criteria:\n\n* History of any cancer in the previous 5 years\n* Bilateral breast cancer\n* Invasive breast cancer treated with neoadjuvant therapy\n* Tumor size clinically and radiologically \\> 5cm\n* Mastectomy candidate\n* Pregnancy and breastfeeding\n* Male breast cancer\n* Unable to understand and fill out questionnaires",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}